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Abstract
Enteropathogenic Escherichia coli (EPEC) represents a major cause of lethal diarrhea in young mammals. Although the
pathogenicity mechanisms of EPEC are now well understood, the intrinsic and environmental factors that control the
expression of EPEC virulence remain largely unknown. In the rabbit, suckling reduces pups’ sensitivity to EPEC infection.
Hence, we have hypothesized that uncharacterized factors present in doemilkmaymediate this protection.Medium chain fatty
acids (MCFA), known to possess antimicrobial properties, are highly abundant in doe milk. We demonstrate that caprylic acid
exhibits a clear bacteriostatic effect in vitro against the rabbit EPEC strain E22 (O103:H2:K-), in a dose-dependent manner. In
vivo, the dietary inclusion of triglycerides of MCFA did not however reduce the sensitivity of young rabbits challenged with
this EPEC strain. The mortality and fecal excretion of EPEC were not reduced, and the bacterial adhesion to ileum was not
inhibited. Amount of MCFA reaching the ileal level might have been too low and/or their association to other milk
antimicrobials may have been required to observe a positive effect on disease evolution in a context of a highly virulent
challenge.
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1. Introduction
Maternal milk is very efficient in preventing
colibacillosis in young rabbits infected with a highly
pathogenic strain of enteropathogenic Escherichia
coli (EPEC) belonging to the O103 serogroup
(Gallois et al., 2007), a dominant serogroup in
French fattening rabbit units (Camguilhem and
Milon, 1989). Milk Igs are not responsible for this
protection (Gallois et al., 2007) and a crossprotec-
tion with Abs directed towards other strains of
E. coli is unlikely, as all trials using heterologous
challenges (Donnenberg et al., 1998) or vaccines
(Milon et al., 1992) failed to demonstrate cross-
protection between different EPEC strains. Less
specific milk components are considered as good
candidates for this protection, through antimicrobial
or immunomodulating properties, or by interfering
with the expression of virulence factors (Baranyi
et al., 2003; Jia et al., 2001; Recio and Visser, 1999;
Cravioto et al., 1991; Sun et al., 2002). Doe milk
composition is very unusual among domestic
mammals. Triglycerides are mainly composed of
medium chain fatty acids (MCFA), with caprylic
(C8:0) and capric (C10:0) acids representing up to
65% (molar proportion) of total fatty acids
(Demarne et al., 1978; Pascual et al., 1999). This
content is very high as compared to other species
such as cows (5%), ewes (17%), goats (18%) or
humans (2.5%) (Freeman et al., 1965). MCFA are
very active antimicrobials in vitro, including
against coliforms (Sun et al., 2002; Marounek
et al., 2002). In vivo, MCFA have been implicated in
the control of the stomacal microflora in suckling
rabbits (Canas-Rodriguez and Smith, 1966), and
provide health benefits during the post-weaning
period (Skrivanova et al., 2004). The known
antimicrobial properties of MCFA and their parti-
cularly high content in doe milk led us to
determine whether MCFA could protect pups
against colibacillosis during suckling. In this study,
the bacteriostatic activity of MCFA against EPEC
were demonstrated in vitro. The disease evolution
was studied in vivo in rabbits inoculated with a
non-pathogenic (BM21) or a pathogenic strain of
E. coli (strain E22, O103:H2:K-), and fed with a
diet supplemented or not with triglycerides of
MCFA.
2. Material and methods
2.1. Bacterial strains
An enteropathogenic E. coli strain belonging
to O103:H2:K- serotype (E22 strain), which does
not metabolize the rhamnose and is fimbriae AF/R2
positive (Camguilhem and Milon, 1989), and the
non-pathogenic BM21 strain of E. coli (Boullier
et al., 2003a) were used in this study. For
the inhibition of adhesion assay, a genetically
modified pEGFP-E22 strain was used (Boullier
et al., 2003b).
2.2. In vitro experiments
Antimicrobial properties of MCFA were evalu-
ated in vitro as follows. Solutions of C8:0, C10:0
(Sigma) and of a mix of both, ranging from 0 to
40 mM, were prepared as previously described
(Sun et al., 2002), and adjusted to a pH of 6.5
with NaOH. 103 CFU of E22 were cultured in 5 ml
of MCFA + LB media for 18 h with rotary shaking
or spread on LB agar plate to determine the initial
exact amount of bacteria added to each media. CFU
were counted for each concentration of MCFA
after ON culture on LB agar plates. The inhibition
growth rate was calculated as: (number of
CFU ml1 in LB medium)/(number of CFU ml1
in MCFA medium).
Ability of MCFA to inhibit EPEC adhesion to
epithelial cells was measured on HeLa cells,
cultivated as previously described (Boullier et al.,
2003b). 20 ml of pEGFP-E22 bacteria grown ON
(109 CFU ml1) were pre-incubated with different
amounts of C8:0 and C10:0 media for one hour at RT
prior to their incubation for 30 min with HeLa cells
(Boullier et al., 2003b). After washing, 104 HeLa cells
per sample were immediately acquired with a
Facscalibur (Becton Dickinson). Quantification of
adhesion was monitored using Cellquest software
(Becton Dickinson). The percentage of inhibition was
calculated using the following formula: ((percentage
of pEGFP-E22 + HeLa cells without C8:0-C10:0
media)  (percentage of pEGFP-E22 + HeLa cells
pre-incubated with C8:0–C10:0 media))/(percentage
of pEGFP-E22 + HeLa cells without C8:0–C10:0
media).
2.3. In vivo experiment
This experiment was approved by a regional ethical
committee. 32 litters of 9 rabbits were equally divided
in 4 groups, according to their diet and to the E. coli
strain inoculated at 28 days of age. Pelleted diets,
without antibiotics, were formulated to cover the
nutritional requirements of the young rabbit (Gidenne,
2000) andwere suppliedwith either 2%of sunflower oil
(SO) or 2% of medium chain triglycerides (MCT), a
synthesized oil containing 55% of C8:0 and 44% of
C10:0 (Radia1 7104, Ole´on, France). Chemical
composition of diets was determined according to
European recommendations (EGRAN, 2001), and fatty
acids composition was assayed by the ISTE (In Situ
TransEsterification) method (Park and Goins, 1994).
From 14 to 35 days of age (the day of weaning), does
and their pups were reared in separated cages, to allow
the feeding of pupswith experimental diets provided ad
libitum. Suckling was controlled every morning by
maintaining does with their pups for about 5 min.
Rabbits were orally inoculated at 28 days of age with
104 CFUof BM21 or E22 strains, 3 h after suckling and
were weaned at day 35. Mortality controls were done
twice a day and clinical examination every morning.
Euthanasia was practiced in dying rabbits (intramus-
cular injection of Imalge`ne11000 followed by an
intracardiac injection of T611). Necropsy and a
bacterial analysis of cecal content were systematically
carried out to identify rabbits which died from
colibacillosis. Moreover, bacterial analyses were
performed on 10 g of feces per cage twice a week.
Cecal and fecal enumeration of E. coli was determined
as previously described (Gallois et al., 2007).At 36days
of age, one representative rabbit per litter was
sacrificed, in order to analyze composition of stomacal
and ileal contents in fatty acids according to the ISTE
method (Park and Goins, 1994). At 63 days of age, all
remaining rabbits were sacrificed. Survival rates were
submitted to a x2 test (procedure CATMOD, SAS
Online1). Bacterial shedding and MCFA composition
of digestive contents were analyzed with the GLM
procedure (SASOnline1), depending on diet, the strain
of E. coli and their interaction as main effects. On day
28, two additional litters of nine MCT or SO-fed
suckling rabbits were inoculated with 104 CFU of E22
strain, and sacrificed 3 days later. Distal ileum was
fixed in 10% formaldehyde and embedded in paraffin.
Bacteria fixed on the epithelia were revealed with an
anti-E22 serum prepared in the laboratory (Boullier
et al., 2003b). Tissue samples were scored blindly for
bacterial adhesion.
3. Results
3.1. MCFA inhibit bacterial growth in vitro
The possible bacteriostatic or bactericidal effects of
MCFA were first tested against E22 bacteria in vitro.
At any tested concentrations, C8:0 did not display any
detectable bactericidal or bacteriostatic effect, with an
inhibition rate inferior to 1 log at 40 mM (5.76 g kg1;
Fig. 1). In contrast, C10:0 exhibited a strong dose-
dependent bacteriostatic activity. The mean inhibition
rate reaches values of up to 91 at 40 mM (6.88 g l1).
Interestingly, no synergistic effect was observed
between the two MCFA on the inhibition of bacterial
growth. The dose–response curve obtained was
similar to the one obtained when using C10:0 alone.
There was no detectable bactericidal activity with any
of the MCFA concentrations tested (data not shown).
These in vitro findings prompted us to test whether
MCFA could modify bacterial growth in vivo and
protect rabbits against colibacillosis when added in
pup’s diet.
Fig. 1. C10:0 has a bacteriostatic effect on E22 in vitro. After 18 h of
E22 culture, mean CFU of each type of culture was determined by
plating on LB agar plates in duplicate. Results are expressed as the
rate of growth inhibition for each fatty acid concentration calculated
from the LB control medium. Results represent the mean (S.D.) of
six independent experiments.
3.2. MCT supplementation is inefficient to protect
young rabbits from colibacillosis
The chemical composition of diets was similar
among groups (CP: 17.2%, NDF: 35.9%, starch: 9.3%
on an as-fed basis), with major differences restricted to
their composition in MCFA, MCT diet containing
19% units more C8:0 and 15% units more C10:0 than
SO diet. In E22 groups, the first deaths due to EPEC
occurred on the day of weaning and the mortality rate
reached 50% at 48–49 days of age, whatever the oil
added in feed (Fig. 2A). On day 63, 46 and 44% of
rabbits had survived to colibacillosis in SO-E22 and
MCT-E22 groups, respectively (P = 0.85). None of
BM21-inoculated rabbits died from E22 colibacillo-
sis, and their mortality rate was unaffected by the diet
(P = 0.19). Morbidity, characterized by anorexia,
weight loss, liquid and sometimes hemorrhagic
diarrhea, and dehydration was similar in both E22
groups, and never exceeded 31% on a daily basis
whatever the diet (data not shown). Only 12 and 8
rabbits in MCT-E22 and SO-E22 groups, respectively,
did not show any signs of diarrhea all through the
experiment. In BM21 groups, excretion of E. coli
remained stable and no colony belonging to the O103
serogroup was identified (Fig. 2B). In infected rabbits,
fecal excretion of E. coli increased as soon as 31 days
of age, and most colonies were rhamnose negative.
The level of excretion was between 106 and 108 CFU
per g of feces from 31 to 45 days of age, then
decreased to less than 104 CFU per g of feces at the end
of the experiment independently from the diet.
3.3. MCFA does not inhibit bacterial adhesion
in vivo nor in vitro
The addition of MCT in pup’s diet could have
modified the level of ileal bacterial attachment and the
severity of tissue lesions induced by E22. In vivo, the
profile of E22 adhesion was similar among MCT and
SO rabbits, with very rare adhesion spots of bacteria
on the ileum (a mean of two to three colonies per slide)
without any intestinal inflammation lesion (Fig. 3A).
In vitro, we showed that incubation of E22 bacteria
with C8:0 and C10:0 (10–40 mM), alone or combined,
did not reduce their capacity to adhere on HeLa cells
(Fig. 3B).
3.4. Transit of fatty acids along the stomach and
the ileum
AsMCT showed no in vivo beneficial effect against
colibacillosis, we wondered whether the available
amount of MCFA along the digestive tract was
sufficient. As expected, concentrations of C8:0 and
C10:0 were higher in the stomach of MCT-fed rabbits
compared to SO rabbits, both in infected and in
control groups (5.5 times higher for C8:0, P < 0.01,
and 4.1 times higher for C10:0, P < 0.05). These
values reached 18–19 mM for both fatty acids in
MCT-E22 group. In the ileum, the concentrations
of C8:0 and C10:0 also remained higher in MCT
compared to SO rabbits, both in infected and control
Fig. 2. MCT diet does not confer protection against lethal challenge
with O103 EPEC. (A) MCT diet does not limit mortality induced by
E22 strain. 28-day-old rabbits were orally inoculated with 104 CFU
of a non-pathogenic strain BM21 or a pathogenic strain E22 of E.
coli, and fed either with a diet containing 2% of SO or 2% of MCT.
In E22 groups, only rabbits that died from colibacillosis are repre-
sented in the graph. In SO group, none of the rabbits died from E22
colibacillosis. Final survival rates were 45.5, 43.9, 87 and 78.6% in
SO-E22, MCT-E22, SO-BM21 and MCT-BM21 groups, respec-
tively. (B) MCT diet does not limit fecal excretion of E22 strain by
infected rabbits. Total excretion of E. coli is represented by triangles
in BM21 group, and by the height of bars in E22 group. Full bars
indicate the proportion of Rh strains (E22) among E. coli excreted,
hatched bars represent Rh+. SO-fed rabbits are represented in black
and MCT-fed rabbits in grey. Data show arithmetic mean  S.D.
groups (P < 0.001). However, these values were low
and did not exceed 0.1 g kg1 (<0.7 mM) of fresh
ileal content both for C8:0 and C10:0 and were much
lower than the active concentrations tested in vitro.
4. Discussion
In the rabbit, the disease caused by EPEC is
delayed by suckling, which is in agreement with our
previous study (Gallois et al., 2007). Indeed, after
inoculation of 32–42-days-old rabbits with similar
doses of EPEC strains belonging to the O103
serogroup, deaths are classically observed 3–14 days
post-infection (d.p.i.) (Camguilhem and Milon, 1989;
Boullier et al., 2003a). In our study, rabbits mainly
died in a period ranging from 13 to 17 d.p.i., which
corresponds to 6–10 days after weaning. This
protection during the suckling period is not conferred
by specific milk Igs, as all does were seronegative
towards the E22 strain.
Antimicrobial properties of MCFA against bacteria
including coliforms were shown in vitro (Canas-
Rodriguez and Smith, 1966; Marounek et al., 2002;
Sun et al., 2002). In this study, we show that only
C10:0 inhibits the growth of E22 strain at neutral pH.
Despite this clear bacteriostatic effect in vitro, the
dietary inclusion of triglycerides of MCFA does not
reduce the sensitivity of young rabbits to colibacil-
losis. Rates of morbidity and mortality, as well as fecal
E. coli excretion, were similar in all groups of rabbits
regardless of their diet. This could be partly due to an
insufficient MCFA intake. The MCT incorporation
level in diet (2%) was chosen according to the MCFA
content in doe milk and in reference to ingestion
curves of milk/solid feed (Gidenne and Lebas, 2006),
to reach dietary MCFA concentrations similar to the
ones found in milk at the time of weaning. In rabbits
fed withMCT, intake of C8:0 and C10:0 (via feed) was
similar to the intake before weaning (thus via the milk)
(data not shown). Alternatively, intestinal concentra-
tions of MCFA were probably too low to produce a
bacteriostatic effect. For MCFA not to be absorbed too
quickly and thus remain available in EPEC sensitive
tissues (ileum and cecum), they had to be included in
the diet in the form of MCT. In addition, because
medium chain monoglycerides exert a higher anti-
microbial activity than their corresponding free fatty
Fig. 3. C8:0 and C10:0 do not prevent bacterial adhesion in vivo and
in vitro. (A)MCT diet does not modify ileal bacterial attachment and
intestinal inflammation. Ileal tissue sections of MCT-fed (a) or SO-
fed (b) rabbits infected at day 28 and sacrificed at day 31 were
stained with anti-E22 sera and visualized at 400 magnification.
Rabbits from each group presented only scarce bacterial adhesion
(arrow). Villi were intact and no sign of inflammation was visible.
(B) MCFA do not inhibit bacterial adhesion on HeLa cells. Different
concentrations of C8:0 and C10:0 were tested for their ability to
inhibit bacterial adhesion on HeLa cells. Percentage of pEGFP-E22
positive HeLa cells was determined by flow cytometry, by detecting
the GFP expression of pEGFP-E22. Data are mean  S.D. of three
independent experiments.
acids (Isaacs et al., 1995; Petschow et al., 1996),
MCFA absorption needed to be delayed. Feeding
rabbits with MCT should have allowed a slower
absorption of MCFA (Perret, 1980). Their mono-
esterified derivates would have thus reached ileal and
cecal segments. Even if the stomacal and ileal MCFA
contents were higher in MCT-fed rabbits, they
remained lower than 0.2 mg g1 of fresh matter for
both C8:0 and C10:0 in the ileum. It was shown that
C10:0 can inhibit the growth of E. coli at concentra-
tions lower than 0.3 g l1 (2 mM) at a pH of 4.6 (Sun
et al., 2002), but thisminimal inhibiting concentration
increases quickly when the pH nears neutrality (Hsiao
and Siebert, 1999). Accordingly, in the present study,
no bacteriostatic activity of C8:0 even at a dose of
5.76 g l1 (40 mM) was observed at neutral pH (close
to conditions found in rabbit ileum and cecum),
whereas a 2 log bacteriostatic effect was obtained
with C10:0, but at a concentration of 6.88 g l1
(40 mM) which is much higher than the concentra-
tions of MCFA found in the ileum of infected MCT-
fed rabbits (0.16 g kg1). MCT are in part digested
and absorbed at stomacal level (Perret, 1980). Thus,
MCFA and their derivates are likely to be active
mainly in the stomach where high MCFA concentra-
tions are observed, and limit the crossing of pylorus
by pathogenicE. coli. Moreover, acidic pH conditions
in the stomach would be more adapted to the
expression of the antimicrobial activity of MCFA.
If this hypothesis is true, our experimental conditions
(infectious dose/unit of time, highly pathogenic strain
of EPEC) may have been too drastic to allow the
visualization of such phenomenon.
The protection conferred by suckling (Gallois et al.,
2007) is probably the result of a combination of
different milk antimicrobial factors that may act to
limit the virulence of pathogens along the digestive
tract through additive and synergistic effects (Isaacs
et al., 1995). Some components inhibit bacterial
growth while others are more involved in the control
of the colonization of epithelial cells by microorgan-
isms. It was shown that MCFA can limit the invasion
of intestinal epithelial cells by Salmonella enterica in
chicken (Van Immerseel et al., 2004). However, no
inhibition of adhesion of E22 to HeLa cells in presence
of MCFA was observed although an inhibiting
adhesion capacity of milk both in vivo and in vitro
was previously demonstrated (Gallois et al., 2007).
In conclusion, our results show that, despite an in
vitro effect, MCFA alone do not protect rabbits against
colibacillosis. Since the pathogenicity of EPEC is
related to their ability to colonize epithelial cells, it
would be interesting to characterize milk factors able
to inhibit bacterial adhesion. Once characterized, their
use in association with bacteriostatic substances like
MCFA may lead to synergistic effects aiming at
protecting rabbits against colibacillosis.
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